Finance

Beta
Lists
688806:SHA
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CNÂ¥29.69
-10.25%
(-3.39) 1D
Jul 23, 11:29:59 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688806...
Open
CNÂ¥31.00
High
CNÂ¥31.80
Low
CNÂ¥28.58
Avg. vol.
2.36M
Volume
17.44M
52-wk high
CNÂ¥52.52
52-wk low
CNÂ¥28.58
No. of employees
843
Open
CNÂ¥31.00
High
CNÂ¥31.80
Low
CNÂ¥28.58
Avg. vol.
2.36M
Volume
17.44M
52-wk high
CNÂ¥52.52
52-wk low
CNÂ¥28.58
No. of employees
843
News stories
From sources across the web
About Zhuhai Trinomab Pharmaceutical Co., Ltd.
CEO-
Employees843
FoundedDec 17, 2015
Headquarters-
SectorBiotechnology
Websitetrinomab.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Mar 2026
Revenue
169.32K
24.93M
Cost of goods sold
2.75M
14.82M
Cost of revenue
5.91M
12.23M
Research and development expenses
134.32M
39.25M
Total research and development expenses
-
-
Selling, general, and admin expenses
42.63M
66.52M
Operating expense
176.88M
104.70M
Total operating expenses
179.63M
116.93M
Operating income
-182.61M
-94.60M
Other non operating income
-35.74K
-44.26K
EBT including unusual items
-176.72M
-96.50M
EBT excluding unusual items
-182.55M
-97.59M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-84.40K
-210.04K
Net income
-176.72M
-96.38M
Net profit margin
-104,373.22%
-386.64%
Earnings per share
-
-
Interest and investment income
1.39M
884.56K
Interest expense
-4.38M
-5.74M
Net interest expenses
-2.99M
-4.85M
Depreciation and amortization charges
-
-
EBITDA
-165.12M
-85.51M
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer